英文原著

1. Ishida M, Shimabukuro M, Yagi S, Nishimoto S, Kozuka C, Fukuda D, Soeki T, Masuzaki H, Tsutsui M, Sata M. MicroRNA-378 regulates adiponectin expression in adipose tissue: a new plausible mechanism. PLoS One 2014;9(11):e111537. pubmed

2. Kawasaki Y, Hosoya M, Yasumura S, Ohira T, Satoh H, Suzuki H, Sakai A, Ohtsuru A, Takahashi A, Ozasa K, Kobashi G, Kamiya K, Yamashita S, Abe M, Fukushima Health Management Survey G. The basic data for residents aged 16 years or older who received a comprehensive health check examinations in 2011-2012 as a part of the Fukushima Health Management Survey after the great East Japan earthquake. Fukushima J Med Sci 2014;60(2):159-69. pubmed

3. Maeda Y, Inoguchi T, Etoh E, Kodama Y, Sasaki S, Sonoda N, Nawata H, Shimabukuro M, Takayanagi R. Brachial-ankle pulse wave velocity predicts all-cause mortality and cardiovascular events in patients with diabetes: the kyushu prevention study of atherosclerosis. Diabetes Care 2014;37(8):2383-90. pubmed

4. Matsumoto S, Shimabukuro M, Fukuda D, Soeki T, Yamakawa K, Masuzaki H, Sata M. Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser(1177)/Thr(497) of endothelial nitric oxide synthase in diabetic mice. Cardiovasc Diabetol 2014;13:30. pubmed

5. Natsuaki C, Inoguchi T, Maeda Y, Yamada T, Sasaki S, Sonoda N, Shimabukuro M, Nawata H, Takayanagi R. Association of borderline ankle-brachial index with mortality and the incidence of peripheral artery disease in diabetic patients. Atherosclerosis 2014;234(2):360-5. pubmed

6. Shimabukuro M, Higa M, Kinjo R, Yamakawa K, Tanaka H, Kozuka C, Yabiku K, Taira S, Sata M, Masuzaki H. Effects of the brown rice diet on visceral obesity and endothelial function: the BRAVO study. Br J Nutr 2014;111(2):310-20. pubmed

7. Soeki T, Bando S, Uematsu E, Matsuura T, Niki T, Ise T, Kusunose K, Hotchi J, Ueda Y, Tomita N, Yamaguchi K, Yagi S, Fukuda D, Taketani Y, Iwase T, Yamada H, Wakatsuki T, Shimabukuro M, Sata M. Pentraxin 3 is a local inflammatory marker in atrial fibrillation. Heart Vessels 2014;29(5):653-8. pubmed

8. Soeki T, Koshiba K, Niki T, Kusunose K, Yamaguchi K, Yamada H, Wakatsuki T, Shimabukuro M, Minakuchi K, Kishimoto I, Kangawa K, Sata M. Effect of ghrelin on autonomic activity in healthy volunteers. Peptides 2014;62:1-5. pubmed

9. Ueda S, Morimoto T, Ando S-I, Takishita S-I, Kawano Y, Shimamoto K, Ogihara T, Saruta T, the DIME Investigators. A randomised controlled trial for the evaluation of risk for type 2 diabetes in hypertensive patients receiving thiazide diuretics: Diuretics In the Management of Essential hypertension (DIME) study. BMJ Open 2014;4(7). pubmed

10. Yagi S, Hara T, Ueno R, Aihara KI, Fukuda D, Takashima A, Hotchi J, Ise T, Yamaguchi K, Tobiume T, Iwase T, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Akaike M, Sata M. Serum concentration of eicosapentaenoic acid is associated with cognitive function in patients with coronary artery disease. Nutr J 2014;13(1):112. pubmed

11. Yagi S, Kadota M, Aihara K, Nishikawa K, Hara T, Ise T, Ueda Y, Iwase T, Akaike M, Shimabukuro M, Katoh S, Sata M. Association of lower limb muscle mass and energy expenditure with visceral fat mass in healthy men. Diabetol Metab Syndr 2014;6(1):27. pubmed

12. Yamazaki S, Satoh H, Watanabe T. Liraglutide enhances insulin sensitivity by activating AMP-activated protein kinase in male Wistar rats. Endocrinology 2014;155(9):3288-301. pubmed

英文症例

Takashima A, Shimabukuro M, Tabata M, Fukuda D, Uematsu E, Ishibashi-Ueda H, Takanashi S, Sata M. Histopathological heterogeneity of in-stent restenosis in four coronary endarterectomy specimens. Cardiovasc Pathol 2014. pubmed

和文総説

1. 島袋充生, 佐田政隆. 異所性脂肪と心臓脂肪:心臓血管病における新たな病態. J-ISCP会誌 心血管薬物療法 2014;2:35-40.

2. 島袋充生, 益崎裕章. 異所性脂肪と2 型糖尿病. ホルモンと臨床 2014;印刷中.

3. 島袋充生. 【心血管病とバイオマーカー】 糖尿病とバイオマーカー. Angiology Frontier 2014;13(2):141-150.

4. 島袋充生. 【最新肥満症学-基礎・臨床研究の最前線-】 肥満がもたらす病態生理の発症メカニズム 異所性脂肪. 日本臨床 2014;72(増刊4 最新肥満症学):307-314.

5. 島袋充生. 【肥満の医学-臨床と研究の最先端】 基礎研究【Emarging concept】 異所性脂肪と心臓脂肪 生活習慣病のあらたな病態. 医学のあゆみ 2014;250(9):866-870.

6. 島袋充生. 糖尿病治療薬と心血管病 糖尿病と心血管病 糖尿病治療のエビデンスと考え方. メディカル朝日 2014;43(5):42-43.

7. 益崎裕章, 島袋充生. 【境界型糖尿病の診断と治療管理】 境界型糖尿病 α-グルコシダーゼ阻害薬以外の薬物療法の可能性. 月刊糖尿病 2014;6(8):73-80.

8. 益崎裕章, 田仲秀明, 上江冽良尚, 島袋充生. 【最新肥満症学-基礎・臨床研究の最前線-】 沖縄クライシスの現状と今後の課題. 日本臨床 2014;72(増刊4 最新肥満症学):675-681.

9. 益崎裕章, 小塚智沙代, 田仲秀明, 山川研, 島袋充生. 心血管疾患リスクとその対策 メタボリックシンドローム患者における動脈硬化予防戦略 沖縄クライシスからのヒント. 循環plus 2014;14(5):7-9.

10. 益崎裕章, 小塚智沙代, 中山良朗, 島袋充生. 【臓器間代謝ネットワークと糖尿病】 慢性的高脂肪食習慣に伴う視床下部の炎症と小胞体ストレス. Diabetes Frontier 2014;25(1):51-57.